Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v96-EN Version v92-EN
Language English English
Date Updated 2018-12-19 2018-12-11
Drug Identification Number 02443902 02443902
Brand name MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Common or Proper name EMTRICITABINE/TENOFOVIR DISOPROXIL EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 300MG 200MG 300MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30BT 30BT
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-12-19 2018-12-20
Actual start date
Estimated end date 2019-01-11 2019-01-11
Actual end date 2018-12-18
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments